SCHEINBERG DAVID A 4
4 · SELLAS Life Sciences Group, Inc. · Filed Mar 18, 2019
Insider Transaction Report
Form 4
SCHEINBERG DAVID A
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-03-14+25,000→ 25,000 totalExercise: $1.38Exp: 2029-03-14→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will fully vest on the earlier of (x) March 14, 2020 (the first anniversary of the date of grant) or (y) the day prior to the 2020 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.